Literature DB >> 10541113

Management of complex breast cysts.

L A Venta1, J P Kim, C E Pelloski, M Morrow.   

Abstract

OBJECTIVE: This study was undertaken to evaluate the various strategies currently in use to manage complex cysts and specifically address the need for intervention.
MATERIALS AND METHODS: A review of 4562 breast sonograms obtained during an 18-month period revealed 308 complex cysts in 252 women. Data collected from review of patient records included the patient's age and risk factors for breast cancer, aspiration or biopsy results (or both), follow-up imaging studies, and management recommendations.
RESULTS: Management recommendations for complex cysts were 1-year follow-up in 13 patients, 6-month follow-up in 148, sonographically guided aspiration in 82, aspiration with possible core biopsy in 62, and excisional biopsy in three. No malignancies were diagnosed in the group treated with follow-up imaging, sonographically guided aspiration, or excisional biopsy. One malignancy, a papilloma with a 3-mm focus of ductal carcinoma in situ, was diagnosed in one of the patients who underwent core biopsy.
CONCLUSION: Of the lesions classified as complex cysts, the malignancy rate was 0.3% (1/308). This malignancy rate is lower than that for lesions classified as probably benign using mammographic criteria (i.e., for lesions classified as category 3 lesions using the Breast Imaging Reporting and Data System). Because the accepted standard practice for management of probably benign lesions is follow-up studies, the low yield of malignancy in this series suggests that complex cysts can be managed with follow-up imaging studies instead of intervention.

Entities:  

Mesh:

Year:  1999        PMID: 10541113     DOI: 10.2214/ajr.173.5.10541113

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Cystic breast masses and the ACRIN 6666 experience.

Authors:  Wendie A Berg; Alan G Sechtin; Helga Marques; Zheng Zhang
Journal:  Radiol Clin North Am       Date:  2010-09       Impact factor: 2.303

2.  Multiple bilateral circumscribed masses at screening breast US: consider annual follow-up.

Authors:  Wendie A Berg; Zheng Zhang; Jean B Cormack; Ellen B Mendelson
Journal:  Radiology       Date:  2013-04-24       Impact factor: 11.105

3.  Additional role of colour Doppler ultrasound imaging in intracystic breast tumours.

Authors:  O Catalano; M Mattace Raso; M D'Aiuto; L A Illiano; P P Saturnino; A Siani
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

4.  Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.

Authors:  Richard G Barr; Zheng Zhang; Jean B Cormack; Ellen B Mendelson; Wendie A Berg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

5.  Characterization of cysts using differential correlation coefficient values from two dimensional breast elastography: preliminary study.

Authors:  Rebecca C Booi; Paul L Carson; Matthew O'Donnell; Marilyn A Roubidoux; Anne L Hall; Jonathan M Rubin
Journal:  Ultrasound Med Biol       Date:  2007-09-27       Impact factor: 2.998

6.  Benign breast disease and the risk of subsequent breast cancer in African American women.

Authors:  Michele L Cote; Julie J Ruterbusch; Barra Alosh; Sudeshna Bandyopadhyay; Elizabeth Kim; Bassam Albashiti; Bashar Sharaf Aldeen; Derek C Radisky; Marlene H Frost; Daniel W Visscher; Lynn C Hartmann; Warzecha Hind Nassar; Rouba Ali-Femhi
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-19

7.  A highly aggressive invasive ductal carcinoma from a complex cystic breast mass and BI-RADS assessment: A case report.

Authors:  Yixuan Li; Yulan Peng; Xin He
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

8.  Evaluation of Adipokines, Inflammatory Markers, and Sex Hormones in Simple and Complex Breast Cysts' Fluid.

Authors:  Paweł Madej; Grzegorz Franik; Piotr Kurpas; Aleksander Owczarek; Jerzy Chudek; Magdalena Olszanecka-Glinianowicz
Journal:  Dis Markers       Date:  2016-05-12       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.